Novo Nordisk to expand French production facilities
European Pharmaceutical Review
NOVEMBER 24, 2023
These activities are expected to be completed incrementally between 2026 to 2028, the company stated. Recent European manufacturing investments Earlier this month, Novo Nordisk announced that it was planning another manufacturing facility expansion, this time at its site in Kalundborg, Denmark. Construction has already begun.
Let's personalize your content